PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
66.40%
Revenue growth above 1.5x VTLE's 3.68%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
139.84%
Gross profit growth above 1.5x VTLE's 4.25%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
337.00%
EBIT growth above 1.5x VTLE's 6.31%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
337.00%
Operating income growth above 1.5x VTLE's 6.31%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
237.14%
Net income growth under 50% of VTLE's 1926.80%. Michael Burry would suspect the firm is falling well behind a key competitor.
222.00%
EPS growth under 50% of VTLE's 1928.05%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
222.00%
Diluted EPS growth under 50% of VTLE's 1926.83%. Michael Burry would worry about an eroding competitive position or excessive dilution.
13.06%
Share count expansion well above VTLE's 0.40%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.06%
Diluted share count expanding well above VTLE's 0.47%. Michael Burry would fear significant dilution to existing owners' stakes.
-21.03%
Dividend reduction while VTLE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.27%
OCF growth at 50-75% of VTLE's 137.30%. Martin Whitman would question if the firm lags in monetizing sales effectively.
175.36%
FCF growth 1.25-1.5x VTLE's 158.17%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-70.29%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-30.56%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
246.05%
3Y revenue/share CAGR above 1.5x VTLE's 38.07%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-74.80%
Negative 10Y OCF/share CAGR while VTLE stands at 15.36%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-36.62%
Negative 5Y OCF/share CAGR while VTLE is at 0.23%. Joel Greenblatt would question the firm’s operational model or cost structure.
569.07%
3Y OCF/share CAGR above 1.5x VTLE's 109.40%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-23.55%
Negative 10Y net income/share CAGR while VTLE is at 128.04%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.47%
Negative 5Y net income/share CAGR while VTLE is 660.19%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
134.27%
3Y net income/share CAGR 50-75% of VTLE's 215.10%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-77.54%
Negative equity/share CAGR over 10 years while VTLE stands at 58.65%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-21.07%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
25.10%
Below 50% of VTLE's 13625.50%. Michael Burry suspects a serious short-term disadvantage in building book value.
-95.48%
Cut dividends over 10 years while VTLE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-73.17%
Negative 5Y dividend/share CAGR while VTLE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
39.31%
3Y dividend/share CAGR of 39.31% while VTLE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
5.50%
Our AR growth while VTLE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
0.29%
Asset growth well under 50% of VTLE's 4.18%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-14.50%
We have a declining book value while VTLE shows 14.30%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
2.84%
We have some new debt while VTLE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-12.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.